Despite cumulative evidence that the tricyclic drugs result in significant changes in the functioning of brain serotonergic (5-HT) and nordrenergic (NE) systems, such changes have not been found to be associated with recovery from depression. Based up on evidence that the 5-HT and NE systems were associated with different emotions, it was hypothesized that changes in these systems were associated with different components of behavior in drug-responsive patients and not with changes in the "whole" disorder. Findings from this multihospital study of 104 unipolar and bipolar depressed patients showed early drug-associated reductions in anxiety and hostility in treatment responders to precede changes in motor retardation and depressed mood. Adopting this app roach of looking for relationship s between changes in components of major dep ression and changes in neurotransmitter system function, decreases in 5-HT and NE metabolite concentrations in cerebrospinal fluid (CSF) in patients treated with tricyclics, were found to be correlated with changes in sp ecific behaviors. Results indicated the following: (1) drug-induced changes in the 5-HT system to be associated with mood aspects, notably anxiety, and depressed mood; changes in NE primarily with the psychomotor, secondarily with the mood components of the depressed state; (2) the pattern of relationships between changes in 5-HT and in mood in the unipolar was different than that in the bip olar subtype. The results indicate that in detennining the relationship s of biochemical changes to behavioral ones, that it is important to take into account the type of depression (bipolar or unipolar), as well as examining individually and over time those components that make up the disorder of dep ression. These results supp ort evidence that tricyclics have multiple behavioral actions, that response is mediated through changes in sp ecific behaviors and that this app roach warrants further app lication in prospective studies of antidepressant drug mechanisms and their therapeutic actions.
Results indicated the following: (1) drug-induced changes in the 5-HT system to be associated with mood aspects, notably anxiety, and depressed mood; changes in NE primarily with the psychomotor, secondarily with the mood components of the depressed state; (2) the pattern of relationships between changes in 5-HT and in mood in the unipolar was different than that in the bip olar subtype. The results indicate that in detennining the relationship s of biochemical changes to behavioral ones, that it is important to take into account the type of depression (bipolar or unipolar), as well as examining individually and over time those components that make up the disorder of dep ression. These results supp ort evidence that tricyclics have multiple behavioral actions, that response is mediated through changes in sp ecific behaviors and that this app roach warrants further app lication in prospective studies of antidepressant drug mechanisms and their therapeutic actions. [Neuropsychopharmacology 11:89-100, 1994J Despite thirty years of research on the mechanisms of action of the tricyclic drugs, it is unclear, as Delini-Stula (1991) has stated, how these drugs bring about recov-ery in severely depressed patients. Although they have major effects on the functioning of brain serotonergic (5-HT) and noradrenergic (NE) systems, their effects on these systems have not been shown to be directly associated with positive changes in the clinical disor der (Bowden et a1. 1985) . This lack of association be tween a clear change in CSF monoamine concentrations with explicit recovery leaves the relevance of these neu rotransmitter changes to the therapeutic actions of the drugs open to question.
We (Katz and Maas 1994) have previously attrib uted the lack of clarity regarding the role of these neu rotransmitter systems in depression partly to the fail ure to measure drug-associated changes in behavior with the same precision used to investigate biochemi cal changes. Although drug-induced changes in the global severity of the depressive disorder have been well documented in clinical trials of these agents, the actual sequence and type of changes in the component be haviors of treatment-responsive patients remains largely undefined.
A major aim of the collaborative study of the psy chobiology of depression (Katz et a1. 1979; Maas et a1. 1980) was to investigate the mechanism of the therapeu tic action of tricyclic antidepressant drugs. To identify drug actions that were specific to the therapeutic effects, the study focused on neurochemical and behavioral changes in treatment-responsive patients, in contrast to the pattern of change in nonresponsive patients.
With reference to the actions of tricyclic antidepres sant drugs, this study of a multihospital sample of unipolar and bipolar depressed patients determined that the initial actions of the tricyclic drugs amitripty line (AMI) and imipramine (IMI) in treatment-respon sive patients were in reductions in anxiety and hostil ity prior to changes in depressed mood and retardation (Katz et a1. 1987) . The initial changes in anxiety and hostility were correlated with concentrations of AMI in plasma. We interpreted this sequence of changes dur ing treatment as an initial "calming" effect followed within a week by a "stimulating" (reduction of retarda tion or increase of agitation) effect . The results supported the earlier observations of Kielholz (1968) that the efficacy of the drugs was based on mul tiple actions on the behavioral aspects of the disorder.
These findings further indicated that the actions of the tricyclics on 5-HT and NE systems were expressed through the specific components of depression rather than through changes in the disorder as defined globally. Evidence summarized earlier by Carlsson et a1. (1976) that 5-HT and NE neurotransmitter systems were associated with the regulation of different be haviors has been supported by more recent work (e.g., the 5-HT system with aggression) (Jacobs et a1. 1990; van Praag et a1. 1986) , 5-HT with anxiety (Kahn et a1. 1988) , and the NE system with psychomotor activation NEUROPSYCHOPHARMACOLOGY 1994-VOL. 11, NO.2 (Carlsson 1969) , and with arousal and alarm (Redmond et a1. 1986 ). These studies provided the background for the development of hypotheses in this study concern ing how the effects of antidepressants on these systems result in therapeutic changes in depression.
To test hypotheses based on these previous data, we described the depressive disorder in terms of its be havioral, emotive, cognitive, and somatic components. Changes induced by the drugs were then measured through these components. More specifically, we hy pothesized that in patients who responded to treat ment: (1) changes in the functioning of the 5-HT sys tem (as reflected in changes in the concentration of 5-hydroxyindoleacetic acid in CSF) wou ld correlate with changes in hostility and in anxiety; and (2) changes in the NE system (reduction of 3-methoxy-4-hydroxyphenylglycol [MHPG] in CSF) would corre late with changes in "arousal" (anxiety, agitation, somatization) and psychomotor retardation. Most im portantly, these relationships would not be found in pa tients not responsive to treatment. Lastly, because unipolar patients have been found to be significantly more anxious and agitated (Beigel and Murphy 1971; Katz et a1. 1982) , have higher baseline levels of urinary NE and epinephrine (Koslow et a1. 1983) , and different biochemical predictors of treatment response ) than bipolar patients, we proposed (3) that rela tionships between biochemical and behavioral changes will be different in the two clinical subtypes.
METHODS
The methods employed in the National Institute of Mental Health collaborative study of the psychobiol ogy of depression have been written in detail (Maas et a1. 1980; Secunda et a1. 1980; Katz et a1. 1982) . Issues relevant to this report will be briefly summarized.
All patients met the Research Diagnostic Criteria (Spitzer et a1. 1978 ) for a major depressive episode of either the unipolar or bipolar type, as well as met the inclusion and exclusion criteria for primary affective dis order (Robins and Guze 1972) . In this article, "depressed patients" represents unipolar and bipolar patients.
The data presented were obtained from 104 de pressed patients who completed a baseline of 2 weeks of placebo and a 4-week period of drug treatment with either AMI or IMI. Secunda et a1. (1980) have given de tails of the pretreatment and the drug treatment pro tocols. We assigned 125 patients to a particular drug on a random basis, 64 to AMI, and 61 to IMI; however, nine patients did not complete the AMI protocol, and 12 did not complete the IMI protocol (Secunda et aI. 1980) . Thus, of the 104 patients who completed treat ment, 55 received AMI and 49 received 1M!.
Twenty-six unipolar and 23 bipolar patients COffi- pleted treatment with 1M!. Thirty-eight unipolar and 17 bipolar patients completed the AMI protocol. The drugs were administered double-blind, and the dose and schedule were &xed. The dose was raised to 250 mg/day by day seven of treatment. Some patients (13%) were unable to tolerate this dose, so it was de creased (to 100-200 mg/day).
The research protocol required that an evaluation of behavioral response be made weekly and at 21f2 weeks, the expected height of the drug effect. After four weeks of drug treatment (the termination of the study), patients were categorized as responders (essentially re covered), or nonresponders (essentially unrecovered, or with minimal or no change), or as having indeter minate responses. The indeterminate group contained patients who had only a modest response to drug treat ment, and also contained patients who with a longer period of treatment might have eventually met the criteria for recovery or nonrecovery.
Classmcation as a responder or nonresponder was based upon changes in several general indices of the severity of the depressive state (e.g., global scales of severity and improvement, and the Schedule for Affec tive Disorders and Schizophrenia [SADS]-Change Global Assessment Scale) Maas et al. 1984) .
Measurement of the Behavioral and Affect

Components of the Depressed State
Based upon a review of research of the major compo nents of behavior, affect, and expressivity in the clini cal state (Katz et al. 1982 , an extensive inventory of methods was applied for the "multivantaged" anal ysis of depression. Table 1 shows the several vantages and the methods that were used.
Psychometric analyses based on administration of these methods at baseline to a broad sample of patients with affective disorders and based on administration to healthy controls, resulted in the derivation of 11 state constructs that measure the major components of de pression. The constructs include the disturbed emotions of depressed mood, anxiety, and hostility; abnormali ties of motor movement (retardation, agitation, and dis tressed facial expression); maladaptive social behavior; interpersonal sensitivity; somatization (physical com plaints and sleep disorder); and cognitive impairment, which includes both thinking and concentration problems.
Measures of the constructs were drawn from the scales representing each of the vantages. The "anxiety" construct was the result of combining four subfactors: the doctor ratings of anxiety from the live interview (Ta ble 1) based on items from the Hamilton (1960) , the SADS , and the VIBES (Katz et al. 1989) ; the nurses' factor ratings from the WBRS (Raskin et al. 1969 ) and the ADRS (Murphy et al. 1980) ; independent observer ratings from the video interview (VIBES); and the patient's self-report based on factors from the SCL-90 (Derogatis et al. 1974) , and the Na tional Institute of Mental Health (NIMH) Mood Scale (Raskin et al. 1969) .
The factor structure, operational de&nitions of each of the constructs, and research on their reliability and validity have been published (Katz et al. 1982 .
Measurement of behavior for assessment of changes from baseline was initiated following the frrst week of treatment and conducted at 2, 2V2, and 4 weeks during the treatment period.
Biochemical Assays
The neurotransmitter metabolites assayed were 5-HIAA, MHPG, and homovanillic acid (HV A). Lev els of the metabolites in CSF were determined by selected ion monitoring (gas chromatography-mass spectrometry). Details of collection periods, collection methods, and analytic techniques are given by Secunda et al. (1980) ; a brief description follows: Lumbar puncture (LP) was performed between 8:00 A.M. and 9:00 P.M. on protocol pretreatment placebo, day 11 and protocol, day 33 (after 18 days of treatment). The patient has been fasting overnight for 8 hours. The LP was performed with the patient in a sitting position. The 20-ml samples of CSF were kept on ice, then mixed, and divided into aliquots (blind replicates). Sodium metabisulfIte and appropriate in ternal standards were added, and the samples were fro zen at -70°C until analyzed.
All analyses of each substance were completed on coded replicate samples, blind to the subject's diagno sis. Assays on a particular substance were analyzed in a single laboratory, regardless of the center of origin.
The values of the CSF metabolites are expressed as picomoles per milliliter. Because of sample loss, failures in collection, and technical problems, every chemical value was not available for every patient.
Measurement of Drug and Metabolite Plasma Levels
We examined relationships between antidepressant drug levels, treatment response, and pretreatment neu rotransmitter values. Concentrations of IMI and AMI and their metabolites, des methyl imipramine and nor triptyline, were determined in plasma and CSF. The plasma measures were obtained weekly during drug treatment, and the CSF measures were obtained after 18 to 21 days of treatment. The levels of drugs and their demethylated products were determined with gas chro matography-mass spectrometry. In addition to the values for the parent and demethylated drugs, the sum of the two, and the ratio of the demethylated to the pa r ent compound was calculated. A detailed description of the protocol is given by Secunda et al. (1980) ; fur ther reports are in Hanin et al. (1985) , Kocsis et al. (1986) , and Katz et al. (1991) .
Plan of Analysis: Relationships between
Drug-Induced Changes in the CSF Amine
Metabolites and in Specific Behaviors
The values for the CSF amine metabolites in this sam ple of depressed patients, before and after 18 days of treatment with AMI or IMI are in Table 2 . Concentrations of MHPG and 5-HlAA de creased signifIcantly during treatment; by contrast, the level of HV A was the same before and after treatment. There were no differences reflected in the effects of AMI or IMI on MHPG and 5-HIAA levels.
To determine if these drug-induced decreases in CSF concentrations of MHPG and 5-HIAA were linearly related to drug associated changes in behavior at 21f2 weeks of treatment (when steady-state concentrations of the drugs in plasma should have been reached), Pear son product-moment bivariate correlations and multi ple regressions with the behavioral construct as the in dependent variable were computed. Residual values from the regression of scores at 2% weeks on baseline scores were used as measures of change for the be havioral variables (Wittenborn 1966) . Percentage of change was used to control for baseline scores for the biochemical measures because this value had been used in prior analyses . In accordance with the hypotheses, the affects and behaviors mea sured included the constructs of depressed mood, mo tor retardation, anxiety, agitation, and hostility. Vali dation of the hypotheses would occur if decreases in MHPG were correlated with changes in anxiety, agita- tion, and motor retardation, and if decreases in 5-HIAA were correlated with changes in hostility and I or anxiety. The order of analysis was frrst to examine the pat tern of correlations in the total sample of depressed pa tients (Le., both AMI and IMI treated; unipolar and bipolar patients; and responders, indeterminates, and nonresponders) to determine (a) if changes in the neu rotransmitter systems and in the behaviors correlate; (b) the pattern of correlations of patients within that group who achieved recovery within four weeks of treatment (the responders). In order to identify rela tionships that were associated with the therapeutic ac tions of the drugs, the responder pattern was compared with that in the nonresponder group. Second, the pat terns of correlations within the unipolar and bipolar subgroups were examined. Analyses using the total and the responders only, would be conducted in each sub type separately, because as already noted, these types had been previously found to diff er in behavior and baseline biochemistry. Third, the differences in bio chemical-behavioral relationships between the unipo lar and bipolar samples, if any, were analyzed by com paring their patterns and specifIc relationships during treatment, through the utilization of the z test of the signifIcance of difference between correlations (Ed wards 1950). regardless of response type and treatment drug they received, at 2V2 weeks of treatment). 2. Unipolar and bipolar patients, divided into re sponder and nonresponder types: When examin ing the total group of responders to the tricyclic drugs, the following relationships were found to be signifIcant: (a) change in anxiety with change in the concentration of 5-HIAA, and with change in HVA; (b) change in motor retardation with change in the concentration of MHPG; (c) change in the level of hostility with change in the concen tration of MHPG.
RESULTS
Relationships of
These relationships are presented in Table 3 . The positive relationship between changes in 5-HIAA and anxiety indicates that the lesser the decrease in 5-HIAA, the greater the reduction in anxiety; the lesser the de crease in MHPG, the greater the reduction of motor retardation (see Discussion for a likely explanation for this seemingly paradoxical negative correlation). Con versely, the negative relationship of MHPG and hostil ity indicates that the greater the decrease in MHPG, the greater the reduction in hostility.
By contrast, in the nonresponder sample, no signifIcant relationships of changes in the CSF metab olites with change in these behaviors were found (Ta ble 3). 1. Within this sample (IMI or AMI treated; respond ers, indeterminates, and nonresponders): changes in anxiety correlated with changes in the concen tration of 5-HIAA (r = 0.33, P < .05, n = 37) and HV A(r = 0.36, p< .05, n = 36), such that the lesser the decrease in 5-HIAA and the lesser the increase in HVA, the greater the reduction in anxiety. 2. Responder sample: (a) The change in 5-HlAA was correlated with the change in anxiety and with the change in depressed mood such that the increase of, or the less the decrease in 5-HIAA, the greater the reductions in anxiety and depressed mood (Ta ble 4, Figure 1 ). These correlations were absent or in the opposite direction in the nonresponder group. (b) The change in MHPG was correlated with the changes in motor retardation (Figure 2 ), and at a borderline level with depressed mood (p < .10), such that the lesser the decrease in MHPG, the greater the reductions in motor retardation and depressed mood. In the nonresponder group, these correlations were nonsignificant (Table 4 ).
Bipolar Depressions:
1. Total sample (includes AMI and IMI treated; responders, indeterminates, and nonresponders) . The greater the change in 5-HIAA, the greater the changes in anxiety (r = -0.48, P < .05, n = 23), and in depressed mood (r = -0.45, P < .05, n = 23), such that the greater the decrease in 5-HIAA, the greater the reductions in anxiety and in depressed mood. The nonresponder sample was inadequate for cor relational analyses. The multiple regression analyses of the data from the total sample and from the unipolar and bipolar subsamples did not add any information to the correlational results; therefore, only the bivari ate analyses are reported. It is evident from Table 4 and Table 5 that although one of the key relationships is the same for unipolar and bipolar groups, the patterns of relationships within the two subtypes are different. SpecifIc fIndings are:
.., o o ::I 1. For the bipolar sample, the decrease in 5-HIAA in the bipolars was directly correlated with the reduction in anxiety and depressed mood; in the unipolar group, in contrast, the lesser the decrease in 5-HIAA, the greater the reduction in anxiety. These relationships were primarily due to the treat ment responders within both groups. 2. Within the responder groups, subtype differences were present. Whereas reductions in 5-HIAA con centrations were correlated with reductions in depressed mood in bipolars, the lesser the de- creases of 5-HIAA in unipolars, the greater the reductions in anxiety and depressed mood. The correlation between reduction in 5-HIAA and depressed mood was 0.54 in unipolar and -0.65 in bipolar depressed patients; the correlation of the reduction in anxiety with the decrease in 5-HIAA in unipolar patients was 0.57 and in bipolars was -0.34. These correlations were in the opposite direction and differed signifIcantly from each other [z test, p < .05 Edwards (1950) ]. 3. In both the unipolar and bipolar samples, the lesser the decrease in MHPG, the greater the reduction in motor retardation.
DISCUSSION
To summarize, the following are conclusions:
1. Drug-induced changes in the functioning of the .. 5-HT, NE, and dopamine systems in severely depressed patients (as reflected in changes in the concentrations of their major metabolites in CSF), were associated with changes in various behavioral components of the disorder. This was evident when patients were separated into unipolar and bipolar, and responder and nomesponder groups. 2. Changes in NE and 5-HT systems were associated differently with the various behaviors and emo tions. 3. Changes in the NE system were found to be as sociated with changes in the motor retardation component of the depressive state in both unipo lar and bipolar patients, but only in treatment responders. There was a borderline association of the change in depressed mood with the change in CSF MHPG, but only in the unipolar responders. 4. Changes in the 5-HT system were associated with changes in the level of anxiety in both unipolar and bipolar subtypes. 5. Changes in the 5-HT system in the responders were associated with changes in depressed mood in the unipolar and bipolar patients, and with changes in anxiety in the unipolars. These associ ations were not found in the nomesponders. 6. The direction of the associations of MHPG con centrations and the motor retardation component were the same for the unipolar and bipolar sub types (i.e., although most responders showed a decrease in motor retardation, the lesser the de crease in MHPG, the greater the reduction in mo tor retardation). 7. The directions of the signifIcant associations for 5-HIAA and anxiety were opposite in the unipo lar and bipolar groups. For the unipolar responders, the lesser the decrease in 5-HIAA, the greater the reductions in anxiety and depressed mood; for the bipolar responders, the greater the decrease in 5-HIAA concentration, the greater the reduction in depressed mood. 8. The greater decrease in HV A in tricyclic drug NEUROPSYCHOPHARMACOLOGY 1994-VOL. 11, NO.2 responders, the greater the decrease in anxiety, The greater the decrease of HV A in bipolar re sponders, the greater the reduction in hostility, Despite the cum ulative evidence that NE and 5-HT systems are associated with the therapeutic action of the tricyclic drugs (Maas et a1. 1991) , it has not been demonstrated that changes in the functioning of these systems play a role in causing recovery in depressed patients (i.e., the same biochemical changes appear to occur in both patients who respond and who do not respond to treatment) (Bowden et a1. 1985) . In this study, the roles of these neurotransmitter systems were measured through their associations with changes in specifIc components of the depressive disorder (anxi ety, depressed mood, hostility, and psychomotor acti vation), rather than changes in the global depressive disorder. This approach demonstrated clear associa tions between biochemical and behavioral changes in patients who responded to treatment.
Differing Behavioral Relationships of the NE and 5-HT Systems
We had previously found that the fIrst facets to change during the process of recovery with these drugs were the levels of anxiety and hostility (Katz et a1. 1991) . The fIndings that certain behavioral components were as sociated directly with the NE and 5-HT systems were suggested by Carlsson et a1. (1969) supporting the ob servations of Kielholz (1968) that the drugs had multi ple actions on the depressive disorder. The association of the NE system with the psychomotor component was supported by our results for depression (Redmond et al. 1986 ) and in this study'S sample of manic patients (Swann et a1. 1987) . Although the association of the 5-HIAA concentration in CSF with the mood aspects of the disorder was hypothesized earlier by investiga tors, the current fIndings identify a somewhat stronger relationship of the 5-HT system with anxiety than with depressed mood. The presumption of a stronger link of 5-HT with anxiety is based on the earlier fInding that the change in anxiety appears to precede the change in depressed mood in the sequence of drug-induced behavioral and mood changes (Katz et aI. 1987) , and in this study's fInding that changes in CSF 5-HIAA were related to changes in anxiety in both bipolar and unipo lar patients.
It is useful at this point to recall that at 21f2 weeks of treatment, the drug responders had changed sig nifIcantly on most facets of the depressive disorder. At this time, therefore, it is more diffIcult to detect differen tial changes among the behavior variables and their specifIc relationships with neurotransmitter variables.
Because the inverse correlation in treatment re sponders between the drug-induced change in MHPG and the motor retardation component of the depressed state was not expected and is difficult to explain, we examined the relationship of change in MHPG to the baseline MHPG level. The correlation was quite sig nifIcant (r = 0.68, p< .01), indicating that those patients with a smaller percentage of change also had lower baseline values of MHPG. We then compared the pa tients with the upper third of baseline values of MHPG (range: 51 pmollrnl to 70 pmollrnl) with the group hav ing the lower third of values (range: 26.9 to 41 pmollrnl) with regard to their 2% week treatment MHPG values and their improvement on motor retardation. The post treatment MHPG mean value for the lower baseline group was 23.9 pmollml, for the higher baseline group, 29.9 (indicating that both groups were apparently mov ing toward the same endpoint). The amount of im provement on motor retardation was, as noted, greater for the lower baseline MHPG group than for the higher baseline group. Even though motor retardation does not show signifIcant improvement until two or three weeks of treatment ), it appears that the lower baseline MHPG group was improving more rapidly than the high baseline group. The inverse corre lation between drug-induced changes in MHPG and motor retardation is therefore somewhat misleading in that despite the lower baseline MHPG group showing a smaller percentage of change, they actually decreased to a lower posttreatment MHPG value than did the high baseline group. The fInding, therefore, indicates that within treatment responders, a relatively low baseline (SF MHPG value (although subject to a lesser percent age change with treatment than a high baseline value) is associated with greater improvement on motor re tardation.
This result is consistent with an earlier fInding that for bipolar patients a lower baseline urinary or CSF MHPG in the depressed sample was associated with a favorable clinical response to tricyclic drugs . That general clinical fInding can now be fur ther specifIed as follows: although most patients re sponsive to tricyclic drugs will improve on motor retardation and depressed mood within 21f2 weeks, those with a low baseline CSF MHPG will improve more rapidly than those patients with a higher base line MHPG, despite the latter group having a propor tionately greater decrease in MHPG. The fInding pro vides evidence that supports low MHPG in CSF as a "marker" in depression (primarily in bipolar patients) for response to tricyclic drugs and that within treatment responders, it is associated with more rapid improve ment in motor retardation.
The nature of the associations of neurotransmitter and behavioral changes would be more clearly defIned if these relationships could have been examined ear lier in treatment (i.e., within the frrst seven to ten days, when differences in effects across the various behaviors Drugs, Neurotransmitters, and Behavioral Change 97 in the responders were clearly present). Nevertheless, resolution from this analysis is evident at 21f2 weeks among the various relationships, and certain signifIcant associations appear to be consistent with earlier re search. The changes in the NE system were correlated more highly with the psychomotor component of the depressive state, secondarily with mood. By contrast for the 5-HT system, the changes were primarily as sociated with mood aspects, notably anxiety, and depressed mood. The fIndings reinforce that these neu rotransmitter systems, although partially overlapping in their functioning, are associated with the expression or regulation of a different pattern of behaviors and emotions.
Differences between the Patterns of Relationships within the Unipolar and Bipolar Subtypes
Although change in MHPG correlated with change in motor retardation of the treatment responders, the rela tionship between 5-HlAA and anxiety and/or depressed mood was an inverse one in the unipolars and in the positive direction for the bipolars.
There is controversy about whether the decrease of 5-HIAA in CSF to a level signifIcantly below that of healthy controls (Koslow et al. 1983 ) is or is not a reflec tion of an enhancement in 5-HT transmission in the brain (Eriksson and Humble 1990; Meltzer 1990) . If the decrease in 5-HIAA is a reflection of enhanced trans mission within the 5-HT system, than its association with the reductions in depressed mood and anxiety in bipolar depressions (along with the associated improve ment in motor retardation) would explain in great part the therapeutic action of the tricyclic drugs in this form of the disorder. The inverse association of changes in 5-HIAA and anxiety in unipolars indicated that the smaller the decrease or an increase (Figure 1 ) of 5-HIAA, the more improvement in anxiety (baseline and change in CSF 5-HIAA unlike the case with MHPG, were not correlated). This suggests that the role of the 5-HT sys tem is different in this form of depression, or irrelevant to the therapeutic action of the drug.
The level of anxiety is signifIcantly higher in unipo lar than in bipolar patients (Beigel and Murphy 1971; Katz et al. 1982) , and it appears therefore, that as with the earlier fIndings of differences in their behavior and baseline chemistry, the biochemical changes induced by the drugs relate in different ways to behavior and emotions in the unipolar and bipolar subtypes. It pro vides additional evidence that the unipolar and bipo lar types, despite their comparable rates of response to the drugs, represent different disorders. The prac tice in earlier research of merging these two subtypes of patients partly explains why results in small sample studies on these issues were often conflicting.
On Mechanisms of Action of Tricyclic Drugs
These results reinforce that the tricyclic drugs have mul tiple actions that are mediated through changes in the NE and 5-HT systems and through ways that are presently unknown.
In light of the association of changes in the 5-HT system with changes in aspects of mood, notably anxi ety (the common aspect of most psychopathologic states) and depressed mood, the new selective 5-HT antidepressants would be expected to fmd applications for other mental disorders. The 5-HT drugs have been found to be effective for specific anxiety states (Deakin et a1. 1991) similarly to the tricyclics, and in addition, for obsessive-compulsive states (InseI1991) where anxi ety is presumed a major role in the disorder and psy chomotor disturbance (more highly associated with the functioning of the NE system), a lesser role.
Because of the complexity of the ways these neu rotransmitter systems interact (Potter et a1. 1989; Maas et a1. 1991) and the different nature of their relation ships with behavior, it is evident that to uncover the specificity of each neurotransmitter system, future studies must apply more refined behavioral measures. In particular, the manner in which the new targeted drugs affect these neurochemical-behavioral interac tions in different disorders needs to be examined at sev eral timepoints during treatment.
To uncover the relationships between drug-induced changes in brain biochemistry and specific changes in behavior in the unipolar and bipolar forms of depres sion will also require measures of brain neurotransmit ter functioning that are more direct and clearly inter pretable. This study utilized indirect or secondary measures of brain neurotransmitter functioning. To the extent that more direct measures of brain neural trans mission (e.g., positron emission topography, in vivo measures of receptor activity) can be used in conjunc tion with refined measures of behavior, applied sequen tially during treatment, we should obtain even clearer information regarding the mechanisms of antidepres sant drug action.
In conclusion:
1. Drug-induced changes in 5-HT and NE systems were directly related to changes in critical be havioral and emotional components of the depres sive disorder, but not to the disorder as a whole. 2. NE and 5-HT systems appear to relate differently to these behavioral facets (i.e., the NE system more consistently with the psychomotor component of the depressed state than with mood aspects, whereas the 5-HT system is more related to the mood aspects of the disorder, notably anxiety and depressed mood). 3. During treatment, these affect and motor compo-nents appear to change at different rates reflect ing the multiple actions of the tricyclic drugs. In severe depression, anxiety and agitation in one re spect, and depressed mood and retardation in an other, reflect opposed states of arousal that appear to be equally focal to the disorder. They therefore, can represent separate targets for treatment, as can hostility, which also is a critical facet of the de pressed state. 4. In accordance with diff erences in the baseline bio chemistry and behavior of the unipolar and bipo lar subtypes, the drug-induced changes in their biochemistry related differently to behavioral changes in the two subtypes. This provided fur ther evidence that the unipolar and bipolar types represent different disorders. 5. The relationships of baseline and the amount of change in the NE system to the psychomotor com ponent of the depressive disorder was the same �n the unipolar and bipolar subtypes. This finding m treatment responders in addition to the earlier finding, that a lower concentration of MHPG in C�F is associated with a positive response to tricy chc drugs provides further evidence that baseline MHPG level is a marker for response to antidepres sants.
6. !he relationships of the mood aspects to change m the 5-HT system were different in the two sub types, suggesting that the biochemical and be havioral differences between the unipolar and bipolar disorders are linked to the functioning of the 5-HT system.
